# Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts

> **NCT02377999** · PHASE2 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 40 (actual)

## Conditions studied

- Anogenital Warts

## Interventions

- **DRUG:** Picato

## Key facts

- **NCT ID:** NCT02377999
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02377999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02377999, "Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02377999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*